Cleared Traditional

K060315 - HEALTHSTATS BPRO AMBULATORY BLOOD PRESSURE MONITORING SYSTEM

K060315 is an FDA 510(k) clearance for HEALTHSTATS BPRO AMBULATORY BLOOD PRESS..., manufactured by Healthstats International Pte. , Ltd.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 58-day FDA review.

K060315 · Healthstats International Pte. , Ltd. · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Apr 2006
Decision
58d
Days
Class 2
Risk

K060315 is an FDA 510(k) clearance for the HEALTHSTATS BPRO AMBULATORY BLOOD PRESSURE MONITORING SYSTEM. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Healthstats International Pte. , Ltd. (Egale, US). The FDA issued a Cleared decision on April 7, 2006 after a review of 58 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Healthstats International Pte. , Ltd. devices

FDA 510(k) Submission Details - K060315

510(k) Number K060315 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 08, 2006
Decision Date April 07, 2006
Days to Decision 58 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
67d faster than avg
Panel avg: 125d · This submission: 58d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 1031
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K060315.
HOMMED CENTRAL STATION, VERSION 3.5
K053453 · Honeywell Hommed, LLC · May 2006
HL888SF
K060835 · Health & Life Co., Ltd. · Apr 2006
FULL AUTOMATIC (NIBP) BLOOD PRESSURE MONITOR, MODEL HL168FV
K060729 · Health & Life Co., Ltd. · Apr 2006
ROSSMAX AUTOMATIC BLOOD PRESSURE MONITOR MODEL MO701K
K060342 · Rossmax International , Ltd. · Apr 2006
PMP4 BP PRO BLOOD PRESSURE MONITOR
K060703 · Card Guard Scientific Survival , Ltd. · Apr 2006
IDEAL LIFE BP-MANAGER, MODEL BPM 0001
K060504 · Ideal Life, Inc. · Mar 2006